{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:06:08Z","timestamp":1778583968122,"version":"3.51.4"},"reference-count":21,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1488,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1111\/j.1476-5381.2011.01340.x","type":"journal-article","created":{"date-parts":[[2011,3,17]],"date-time":"2011-03-17T07:45:44Z","timestamp":1300347944000},"page":"181-191","source":"Crossref","is-referenced-by-count":62,"title":["TS-071 is a novel, potent and selective renal sodium-glucose cotransporter 2 (SGLT2) inhibitor with anti-hyperglycaemic activity"],"prefix":"10.1111","volume":"164","author":[{"given":"K","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Okumura-Kitajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Gunji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Kozakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Tomoike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Asami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,8,5]]},"reference":[{"issue":"1","key":"10.1111\/j.1476-5381.2011.01340.x-BIB1|cit1","first-page":"S1","article-title":"Guide to receptors and channels (GRAC), 4th edition","volume":"158","author":"Alexander","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"13800","DOI":"10.1016\/S0021-9258(18)77419-X","article-title":"Insulin regulation of the two glucose transporters in 3T3-L1 adipocytes","volume":"265","author":"Calderhead","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/dmrr.532","article-title":"Phlorizin: a review","volume":"21","author":"Ehrenkranz","year":"2005","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/jpet.108.140210","article-title":"Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models","volume":"327","author":"Fujimori","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2337\/db07-1472","article-title":"Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats","volume":"57","author":"Han","year":"2008","journal-title":"Diabetes"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1152\/physrev.1994.74.4.993","article-title":"Molecular physiology of sodium-glucose cotransporters","volume":"74","author":"Hediger","year":"1994","journal-title":"Physiol Rev"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.287.3.360","article-title":"Oral antihyperglycemic therapy for type 2 diabetes: scientific review","volume":"287","author":"Inzucchi","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1021\/jm901893x","article-title":"(1S)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-D-glucitol (TS-071) is a potent, selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for type 2 diabetes treatment","volume":"53","author":"Kakinuma","year":"2010","journal-title":"J Med Chem"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB10|cit9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1172\/JCI116972","article-title":"The human kidney low affinity Na+\/glucose cotransporter SGLT2, Delineation of the major renal reabsorptive mechanism for D-glucose","volume":"93","author":"Kanai","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB9|cit10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.106.110296","article-title":"Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level","volume":"320","author":"Katsuno","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukaryotic vector","volume":"108","author":"Niwa","year":"1991","journal-title":"Gene"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.2337\/diabetes.48.9.1794","article-title":"T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes","volume":"48","author":"Oku","year":"1999","journal-title":"Diabetes"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.nu.16.070196.001315","article-title":"Structure, function, and regulation of the mammalian facilitative glucose transporter gene family","volume":"16","author":"Olson","year":"1996","journal-title":"Annu Rev Nutr"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB14|cit14","first-page":"91","article-title":"Studies on the diabetogenic action of streptozotocin (NSC-37917)","volume":"29","author":"Rakieten","year":"1963","journal-title":"Cancer Chemother Rep"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1097\/01.ASN.0000092790.89332.D2","article-title":"Molecular analysis of the SGLT2 gene in patients with renal glucosuria","volume":"14","author":"Santer","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB16|cit16","first-page":"2017","volume-title":"Handbook of Physiology, Section 8: Renal Physiology Vol. 2","author":"Silverman","year":"1992"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1681\/ASN.2010030246","article-title":"SGLT2 mediates glucose reabsorption in the early proximal tubule","volume":"22","author":"Vallon","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB19|cit18","doi-asserted-by":"crossref","first-page":"F10","DOI":"10.1152\/ajprenal.2001.280.1.F10","article-title":"Renal Na+-glucose cotransporters","volume":"280","author":"Wright","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB18|cit19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1385\/CBB:36:2-3:115","article-title":"Molecular basis for glucose-galactose malabsorption","volume":"36","author":"Wright","year":"2002","journal-title":"Cell Biochem Biophys"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"29365","DOI":"10.1074\/jbc.270.49.29365","article-title":"Molecular characteristics of Na+-coupled glucose transporters in adult and embryonic rat kidney","volume":"270","author":"You","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1476-5381.2011.01340.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jcb.10631","article-title":"Human cardiomyocytes express high level of Na+\/glucose cotransporter 1 (SGLT1)","volume":"90","author":"Zhou","year":"2003","journal-title":"J Cell Biochem"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2011.01340.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1476-5381.2011.01340.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T12:01:00Z","timestamp":1637409660000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2011.01340.x"}},"subtitle":["TS-071, SGLT2 inhibitor, anti-diabetic agent"],"short-title":[],"issued":{"date-parts":[[2011,8,5]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01340.x","relation":{},"ISSN":["0007-1188"],"issn-type":[{"value":"0007-1188","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8,5]]}}}